Gelayol Asadi
YOU?
Author Swipe
View article: CAR-NK cell therapy in multiple myeloma: from preclinical and clinical landscape to joining the force for treatment strategies optimization
CAR-NK cell therapy in multiple myeloma: from preclinical and clinical landscape to joining the force for treatment strategies optimization Open
Natural killer (NK) cells are specialized components of the innate immune system with an essential role in immune surveillance against multiple myeloma (MM). However, patients with MM often exhibit significant impairments in both the quant…
View article: Comparison of the efficacy of combined budesonide and fexofenadine versus combined fluticasone propionate and fexofenadine on the expression of class-4 semaphorins and their receptors in the peripheral blood cells of patients with allergic rhinitis
Comparison of the efficacy of combined budesonide and fexofenadine versus combined fluticasone propionate and fexofenadine on the expression of class-4 semaphorins and their receptors in the peripheral blood cells of patients with allergic rhinitis Open
In conclusion, concomitant use of fexofenadine and fluticasone propionate reduced SEMA4A, 4C, 4D, Plexin-B2, and Plexin-D1, while the SEMA4A, 4C, Plexin-B2, and Plexin-D1 gene expression levels wer…
View article: Altered Expression of Long Non-Coding RNAs NEAT1, H19, and MALAT1 in Peripheral Blood Cells of Patients with Allergic Rhinitis after Treatment with Pharmaceutical Combinations of Budesonide and Fexofenadine versus Fluticasone Propionate and Fexofenadine
Altered Expression of Long Non-Coding RNAs NEAT1, H19, and MALAT1 in Peripheral Blood Cells of Patients with Allergic Rhinitis after Treatment with Pharmaceutical Combinations of Budesonide and Fexofenadine versus Fluticasone Propionate and Fexofenadine Open
View article: Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review"
Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review" Open
View article: Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review"
Author response for "Clinical, immunological, and genetic features in 780 patients with autoimmune lymphoproliferative syndrome (ALPS) and ALPS-like diseases: A systematic review" Open